On Tuesday, Shares of Rite Aid Corporation (NYSE:RAD), lost -1.73% to $8.51.
Rite Aid Corporation, declared that Mike Podgurski, Rite Aid’s vice president of pharmacy services, has been named the 2015 Honorary President by the National Association of the Boards of Pharmacy (NABP).
The honor is awarded each year to an individual in recognition of their commitment to supporting the Association’s mission and aims counting protecting public health and promoting the Association’s initiatives. Podgurski, a licensed pharmacist with more than 40 years’ experience, was formally recognized during NABP’s Annual Awards Dinner yesterday, the culminating event of the Association’s 111th Annual Meeting in New Orleans.
“Over the course of his career, Mike has made a profound and lasting impact here at Rite Aid and across the retail pharmacy industry,” said Robert Thompson, Rite Aid executive vice president of pharmacy. “We are extremely proud of Mike and we are especially grateful for his many contributions to our company, which have assisted us to deliver superior patient care to our pharmacy customers nationwide. Mike is a true servant leader and a champion of community pharmacy and is most-deserving of this honor.”
In presenting the award, the Association recognized Mike’s ongoing commitment to the Association through his participation on numerous NABP and industry committees and task forces counting the NABP’s Task Force on Pharmacy Licensure Standards, its Community Pharmacy Accreditation Program Steering Committee and its Task Force on Pharmacy Automation; the American Pharmacists Association’s Work Group on the Future of Pharmacy, and the Food and Drug Administration’s Risk Communication Advisory Committee. He was also involved with the White House Office of National Drug Control Policy Roundtable on Health Information Technology and Prescription Drug Abuse and the Office of the National Coordinator for Health Information Technology and Substance Abuse and Mental Health Services Administration Prescription Drug Monitoring Program Work Group.
Rite Aid Corporation, through its auxiliaries, operates a chain of retail drugstores in the United States. The company sells prescription drugs and a range of other merchandise, counting over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.
Shares of AK Steel Holding Corporation (NYSE:AKS), inclined 4.82% to $5.44, during its last trading session.
AK Steel, sold its half of a steel coating company for $25.2 million.
The West Chester-based steel maker late last week inked a deal to sell its interest Double Eagle Steel Coating Co. in Dearborn, Mich. to Pittsburgh-based United States Steel Corp.
AK Steel (NYSE:AKS) attained Double Eagle last fall as part of a bigger deal to buy Severstal Dearborn LLC.
U.S. Steel (NYSE: X) will make the 700,000 ton electrolytic-galvanizing line at Double Eagle part of the larger operational footprint of its Great Lakes Works. It will be used primarily for customers in the automotive industry. AK Steel never used the Double Eagle facility and money from the sale will go towards its liquidity.
AK Steel is one of the largest local companies — and also one of the few public companies in the region — so its financial health carries a big economic impact here. It has about 2,400 local employees and posted $6.5 billion in revenue in 2014.
AK Steel Holding Corporation, through its partner, AK Steel Corporation, produces flat-rolled carbon, stainless and electrical steel, and tubular products in the United States and internationally. It produces flat-rolled value-added carbon steels, counting coated, cold-rolled, and hot-rolled carbon steel products; and specialty stainless and electrical steels in sheet and strip forms.
At the end of Tuesday’s trade, Shares of Valero Energy Corporation (NYSE:VLO), lost -0.46% to $58.51, despite Energy stocks jumped as the price of oil continues to climb. U.S. benchmark crude was up 1.9% to $61.35 a barrel on the New York Mercantile Exchange.
Valero Energy Corporation operates as an independent petroleum refining and marketing company in the United States, Canada, the Caribbean, the United Kingdom, and Ireland. It operates through two segments, Refining and Ethanol.
Finally, EnteroMedics Inc. (NASDAQ:ETRM), ended its last trade with 5.22% surge, and closed at $1.21.
EnteroMedics, declared the first ever commercial implant of the Maestro® Rechargeable System, delivering vBloc® Neurometabolic Therapy, in the United States.
The procedure was performed on Wednesday, May 13, 2015 at Tufts Medical Center by surgeon Sajani Shah, MD. The surgery proceeded without incident and the patient returned home on the same day as the surgery, is recovering well and has returned to work full-time.
vBloc Therapy intermittently blocks intra-abdominal vagus nerve signaling, or transmission of messages involving food intake and processing, between the brain and stomach using a pacemaker-like implant called the Maestro® Rechargeable System. In January of this year, the system was approved for adults with a BMI of 40 to 45 kg/m2 or a BMI of 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels, and who have tried to lose weight in a supervised weight administration program within the past five years.
EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company’s proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.